Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / ORD SHS
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
9,228,073
-
Shares change
-
+414,917
-
Total reported value, excl. options
-
$170,623,993
-
Value change
-
+$8,319,713
-
Number of buys
-
20
-
Number of sells
-
20
-
Price
-
$18.49
Institutional Holders of NEURODERM LTD - ORD SHS as of Q3 2016
As of 30 Sep 2016 NEURODERM LTD - ORD SHS had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,228,073 shares of stock of the company.
Largest 10 holders included SCOPIA CAPITAL MANAGEMENT LP, Redmile Group, LLC, venBio Select Advisor LLC, MENORA MIVTACHIM HOLDINGS LTD., ACUTA CAPITAL PARTNERS, LLC, BlackRock Fund Advisors, BAKER BROS. ADVISORS LP, ADAGE CAPITAL PARTNERS GP, L.L.C., PERCEPTIVE ADVISORS LLC, and Arrowpoint Asset Management, LLC.
This table shows 48 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.